European Journal of Internal Medicine
Volume 19, Issue 8 , Pages 568-574 , December 2008

The syndrome of rhabdomyolysis: Complications and treatment

Received 24 April 2007 ,Accepted 21 June 2007.

References 

  1. Poels PJ, Gabreels FJ. Rhabdomyolysis: a review of the literature. Clin Neurol Neurosurg. 1993;95:175–192
  2. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000;11:1553–1556
  3. Knochel JP. Mechanisms of rhabdomyolysis. Curr Opin Rheumatol. 1993;5:725–731
  4. Giannoglou GD, Chatzizisis YS, Misirli G. The syndrome of rhabdomyolysis: pathophysiology and diagnosis. Eur J Int Med. 2007;18:90–100
  5. Dimaur S, Andreu AL, Bruno C, Hadjigeorgiou GM. Myophosphorylase deficiency (glycogenosis type V; McArdle disease). Curr Mol Med. 2002;2(2):189–196
  6. Warren J, Blumbergs P, Thompson P. Rhabdomyolysis: a review. Muscle Nerve. 2002;25:332–347
  7. Better OS. Post-traumatic acute renal failure: pathogenesis and prophylaxis. Nephrol Dial Transplant. 1992;7:260–264
  8. Better OS, Rubinstein I, Reis DN. Muscle crush compartment syndrome: fulminant local edema with threatening systemic effects. Kidney Int. 2003;63:1155–1157
  9. Larbi EB. Drug-induced rhabdomyolysis. Ann Saud Med. 1998;18:525–530
  10. Allison RC, Bedsole DL. The other medical causes of rhabdomyolysis. Am J Med Sci. 2003;326(2):79–88
  11. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an evaluation of 475 hospitalized patients. Medicine. 2005;84(6):377–385
  12. Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve. 2002;25(3):332–347
  13. Prendergast BD, George CF. Drug-induced rhabdomyolysis — mechanisms and management. Postgrad Med J. 1993;69:333–336
  14. Zager RA. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int. 1996;49:314–326
  15. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003;289(13):1681–1690
  16. Knochel JP. Neuromuscular manifestations of electrolyte disorders. Am J Med. 1982;72(3):521–535
  17. Nohl H, Gille L, Staniek K. Intracellular generation of reactive oxygen species by mitochondria. Biochem Pharmacol. 2005;69(5):719–723
  18. Gommans IM, Vlak MH, de Haan A, van Engelen BG. Calcium regulation and muscle disease. J Muscle Res Cell Motil. 2002;23(1):59–63
  19. Gordon N. Glycogenosis type V or McArdle's disease. Dev Med Child Neurol. 2003;45(9):640–644
  20. Gonzalez D. Crush syndrome. Crit Care Med. 2005;33(1):S34–S41Supplement
  21. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore). 1982;61:141–153
  22. Koffler A, Friedler R, Massry S. Acute renal failure due to non-traumatic rhabdomyolysis. Ann Int Med. 1976;85(1):23–27
  23. Beetham R. Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem. 2000;37:581–587
  24. Bywaters EGL, Beall D. Crush injuries with impairment of renal function. BMJ. 1941;1:427–432
  25. Chander V, Chopra K. Molsidomine, a nitric oxide donor and l-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Biochim. Biophys. Acta. 2005;1723:208–214
  26. Woodrow G, Brownjohn AM, Turney JH. The clinical and biochemical features of acute renal failure due to rhabdomyolysis. Ren Fail. 1995;17:467–474
  27. Heyman SN, Rosen S, Fuchs S, Epstein FH, Brezis M. Myoglobinuric acute renal failure in rat: a role for medullary hypoperfusion, hypoxia and tubular obstruction. J Am Soc Nephrol. 1996;7:1066–1074
  28. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996;334:1448–1460
  29. Zager RA, Gamelin LM. Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure. Am J Physiol. 1989;256(3 Pt 2):F446–F455
  30. Sandhu JS, Sood A, Midha V, Singh AD, Jain D, Sandhu P. Non-traumatic rhabdomyolysis with acute renal failure. Ren Fail. 2000;22(1):81–86
  31. Sułowicz W, Walatek B, Sydor A, Ochmański W, Miłkowski A, Szymczakiewicz-Multanowska A, et al. Acute renal failure in patients with rhabdomyolysis. Med Sci Monit. 2002;8(1):CR24–CR27
  32. Holt SG, Moore KP. Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intens Care Med. 2001;27:803–811
  33. Lameire N, Vanholder R. New perspectives for prevention/treatment of acute renal failure. Curr Opin Anaesth. 2000;13(2):105–112
  34. Lameire N, De Vriese A, Vanholder R. Prevention and nondialytic treatment of acute renal 0failure. Curr Opin Crit Care. 2003;9(6):481–490
  35. Sheridan AM, Bonventre JV. Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens. 2000;9:427–434
  36. Badr KF, Kelley VE, Rennke HG, Brenner BM. Role for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int. 1986;43:1397–1401
  37. Devarajan P. Cellular and molecular derangements in acute tubular necrosis. Curr Opin Pediatr. 2005;17(2):193–199
  38. Zager RA, Prior RB. Gentamycin and gram negative bacteremia: a synergism for the development of experimental nephrotoxic acute renal failure. J Clin Invest. 1986;78:196–204
  39. Furchgott RF, Jothianandan D. Endothelial-dependent and -independent vasodilation involving cGMP: relaxation induced by nitric oxide, carbon oxide and light. Blood Vessels. 1991;28:52–61
  40. Neto LM, Nascimento OR, Tabak M, Caracelli I. The mechanism of reaction of nitrosyl with met and oxymyoglobin: an ESR study. Biochem Biophys Acta. 1988;956:189–196
  41. Sharma VS, Traylor TG, Gardiner R, Mizukami H. Reaction of nitric oxide with heme proteins and model compounds of hemoglobin. Biochemistry. 1987;26:3837–3843
  42. Molitoris BA, Sandoval R, Sutton TA. Endothelial injury and dysfunction in ischemic acute renal failure. Crit Care Med. 2002;30(5):S235–S240Supplement
  43. Slater MS, Mullins RJ. Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review. J Am Coll Surg. 1998;186:693–716
  44. Akimau P, Yoshiya K, Hosotsubo H, Takakuwa T, Tanaka H, Sugimoto H. New experimental model of crush injury of the hindlimbs in rats. J Trauma. 2005;58(1):51–58
  45. Zager R, Burkhart K. Differential effects of glutathione and cysteine on Fe2+, Fe3+, H2O2 and myoglobin-induced proximal tubular cell attack. Kidney Int. 1998;53:1661–1672
  46. Braun SR, Weiss FR, Keller AI, Ciccone JR, Preuss HG. Evaluation of the renal toxicity of heme proteins and their derivatives: a role in the genesis of acute tubular necrosis. J Exp Med. 1970;131:443–460
  47. Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol. 1988;255:F539–F544
  48. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000;109:655–678
  49. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Meth Enzymol. 1990;186:1–85
  50. Zager RA. Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria. Kidney Int. 1996;49:741–751
  51. Moore KP, Holt SG, Patel RP, Svistunenko DA, Zackert W, Goodier D, et al. A causative role for redox cycling and its inhibition by alkalinisation in the pathogenesis and treatment of rhabdomyolysis induced renal failure. J Biol Chem. 1998;273:31731–31737
  52. Holt S, Reeder B, Wilson M, Harvey S, Morrow JD, Roberts LJ, et al. Increased lipid peroxidation in patients with rhabdomyolysis. Lancet. 1999;353:1241
  53. Reeder B, Wilson M. Desferrioxamine inhibits production of cytotoxic heme to protein cross-linked myoglobin: a mechanism to protect against oxidative stress without iron chelation. Chem Res Toxicol. 2005;18(6):1004–1011
  54. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative . Acute renal failure — definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–R212
  55. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis — an overview for clinicians. Crit Care. 2005;9(2):158–169
  56. Criddle LM. Rhabdomyolysis: pathophysiology, recognition, and management. Crit Care Nurse. 2003;23(6):14–30
  57. Allen DG. Skeletal muscle function: role of ionic changes in fatigue, damage and disease. Clin Exp Pharmacol Physiol. 2004;31(8):485–493
  58. Singh D, Chander V, Chopra K. Rhabdomyolysis. Methods Find Exp Clin Pharmacol. 2005;27(1):39–48
  59. Meneghini LF, Oster JR, Camacho JR, Gkonos PJ, Roos BA. Hypercalcemia in association with acute renal failure and rhabdomyolysis. Case report and literature review. Miner Electrolyte Metab. 1993;19(1):1–16
  60. Llach F, Felsenfeld AJ, Haussler MR. The pathophysiology of altered calcium metabolism in rhabdomyolysis-induced acute renal failure. Interactions of parathyroid hormone, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol. N Engl J Med. 1981;305:117–123
  61. Perron A, Brady W, Keats T. Orthopedic pitfalls in the ED: acute compartment syndrome. Am J Emerg Med. 2001;19:413–416
  62. Edwards S. Acute compartment syndrome. Emerg Nurse. 2004;12:32–38
  63. Bonventre J, Shah S, Walker P, Humphrey SM. Rhabdomyolysis induced acute renal failure. In:  Jacobson H,  Striker G,  Klahr S editor. The principles and practice of nephrology. (2nd Ed). St. Louis: Mosby; 1995;p. 569–573
  64. Sion ML, Hatzitolios A, Toulis A, Kounanis A, Prokopidis D. Rhabdomyolysis and acute renal failure associated with Salmonella enteritidis bacteremia. Nephrol Dial Transplant. 1998;13:532
  65. Esson ML, Schrier RW. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med. 2002;137:744–752
  66. Zager RA. Combined mannitol and deferoxamine therapy for myoglobinuric renal injury and oxidant tubular stress: mechanistic and therapeutic implications. J Clin Invest. 1992;90:711–719
  67. Brown CV, Rhee P, Chan L, Evans K, Demetriades D, Velmahos GC. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?. Trauma. 2004;56(6):1191–1196
  68. Gill N, Nally JV, Fatica RA. Renal failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management. Chest. 2005;128:2847–2863
  69. Zager RA, Burkhart KM, Conrad DS, Gmur DJ. Iron, heme oxygenase and glutathione: effects on myoglobinuric proximal tubular injury. Kidney Int. 1995;48:1624–1634
  70. Lopez JR, Rojas B, Gonzales MA, Terzic A. Myoplasmic Ca2+ concentration during exertional rhabdomyolysis. Lancet. 1995;345:424–425
  71. Knochel JP. Pigment nephropathy. In:  Greenberg A editors. Primer on kidney diseases. (2nd Ed). Boston: Academic Press; 1998;p. 273–276
  72. Russell TA. Acute renal failure related to rhabdomyolysis: pathophysiology, diagnosis and collaborative management. Nephrol Nurs J. 2000;27:567–575
  73. Brady HR, Brenner BM. Acute renal failure. In:  Fauci AS,  Braunwalld E,  Isselbacher KJ,  Wilson JD,  Martin JB,  Kasper DL,  Hauser SL,  Longo DL editor. Harrison's principles of internal medicine. (14th Ed). McGraw-Hill; 1998;p. 1505–1513
  74. Harriston S. A review of rhabdomyolysis. Dimens Crit Care Nurs. 2004;23(4):155–161
  75. Gozal Y. Calcium administration in rhabdomyolysis may be detrimental. Anesth Analg. 1996;82:185–186

PII: S0953-6205(08)00083-6

doi: 10.1016/j.ejim.2007.06.037

European Journal of Internal Medicine
Volume 19, Issue 8 , Pages 568-574 , December 2008

Article Tools

* Image Usage & Resolution